Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Baraclude
U.S. court invalidates patent on Bristol hepatitis B drug
U.S. court invalidates patent on Bristol hepatitis B drug
Reuters
Baraclude
Bristol-Myers Squibb
hepatitis B
patents
News
Bristol-Myers Squibb: Outstanding Pipeline Makes It Most Attractive Among Large Pharmaceuticals
Seeking Alpha
Baraclude
Bristol-Myers Squibb
chronic myeloid leukemia
diabetes
hepatitis B
HIV
Onglyza
Orencia
pipelines
Reyataz
rheumatoid arthritis
Sprycel
News
BARACLUDE® (entecavir) Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
Yahoo/Business Wire
Adefovir
Baraclude
hepatitis B
»
Login
or
register
to post comments
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT